These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 19747122)

  • 1. HIV-1 IN inhibitors: 2010 update and perspectives.
    Marchand C; Maddali K; Métifiot M; Pommier Y
    Curr Top Med Chem; 2009; 9(11):1016-37. PubMed ID: 19747122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial.
    Johnson AA; Marchand C; Pommier Y
    Curr Top Med Chem; 2004; 4(10):1059-77. PubMed ID: 15193139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 integrase inhibitors: 2007-2008 update.
    Ramkumar K; Serrao E; Odde S; Neamati N
    Med Res Rev; 2010 Nov; 30(6):890-954. PubMed ID: 20135632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrase inhibitors for the treatment of HIV infection.
    Pace P; Rowley M
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):471-9. PubMed ID: 18600564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Authentic HIV-1 integrase inhibitors.
    Liao C; Marchand C; Burke TR; Pommier Y; Nicklaus MC
    Future Med Chem; 2010 Jul; 2(7):1107-22. PubMed ID: 21426159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants.
    Marinello J; Marchand C; Mott BT; Bain A; Thomas CJ; Pommier Y
    Biochemistry; 2008 Sep; 47(36):9345-54. PubMed ID: 18702518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.
    Zhao XZ; Maddali K; Metifiot M; Smith SJ; Vu BC; Marchand C; Hughes SH; Pommier Y; Burke TR
    Chem Biol Drug Des; 2012 Feb; 79(2):157-65. PubMed ID: 22107736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of integrase inhibitors of HIV-1.
    Malet I; Calvez V; Marcelin AG
    Curr Opin Virol; 2012 Oct; 2(5):580-7. PubMed ID: 22980926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of second-generation HIV integrase inhibitors: targeting integration beyond strand transfer.
    Voet AR; Maeyer MD; Debyser Z; Christ F
    Future Med Chem; 2009 Oct; 1(7):1259-74. PubMed ID: 21426102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence.
    Mesplède T; Wainberg MA
    Viruses; 2015 Jul; 7(7):3703-18. PubMed ID: 26198244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.
    Engelman AN
    J Biol Chem; 2019 Oct; 294(41):15137-15157. PubMed ID: 31467082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.
    Hadi V; Koh YH; Sanchez TW; Barrios D; Neamati N; Jung KW
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6854-7. PubMed ID: 20864343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of HIV-1 M group polymorphisms on integrase inhibitor efficacy and resistance: genetic and structural in silico analyses.
    Loizidou EZ; Kousiappa I; Zeinalipour-Yazdi CD; Van de Vijver DA; Kostrikis LG
    Biochemistry; 2009 Jan; 48(1):4-6. PubMed ID: 19090674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
    Malet I; Subra F; Charpentier C; Collin G; Descamps D; Calvez V; Marcelin AG; Delelis O
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Integrase Enzyme: A Therapeutic Approach to Combat HIV Resistance.
    Komal D; Khushboo J; Aaftaab S; Lakshmi S; Mallika A
    Mini Rev Med Chem; 2020; 20(3):219-238. PubMed ID: 31613727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV integrase inhibitors: 20-year landmark and challenges.
    Métifiot M; Marchand C; Pommier Y
    Adv Pharmacol; 2013; 67():75-105. PubMed ID: 23885999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitors.
    Peese KM; Naidu BN; Patel M; Li C; Langley DR; Terry B; Protack T; Gali V; Lin Z; Samanta HK; Zheng M; Jenkins S; Dicker IB; Krystal MR; Meanwell NA; Walker MA
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126784. PubMed ID: 31761656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-0536 inhibits HIV-1 integrases resistant to raltegravir.
    Métifiot M; Johnson B; Smith S; Zhao XZ; Marchand C; Burke T; Hughes S; Pommier Y
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5127-33. PubMed ID: 21876054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrase inhibitors in the treatment of HIV-1 infection.
    Powderly WG
    J Antimicrob Chemother; 2010 Dec; 65(12):2485-8. PubMed ID: 20852268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.